Photodamaged Skin Clinical Trial
Official title:
Treatment of Photodamaged Skin of the décolleté With Fractional Laser, Radio-frequency Microneedling, and Photodynamic Therapy
Verified date | July 2020 |
Source | Bispebjerg Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study investigates a non-ablative fractional thulium laser and a radio-frequency microneedling device as pre-treatment for combination photodynamic therapy in treatment of photoaged skin and actinic keratoses.
Status | Terminated |
Enrollment | 12 |
Est. completion date | December 18, 2018 |
Est. primary completion date | December 18, 2018 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Décolleté with chronic field-change photodamaged skin. - Area with visually homogenous photodamage. - Provide informed written consent. - Fertile women must provide a negative U-hCG pregnancy test at the time of inclusion, and use safe anticontraceptive during the entire study period, e.g. oral hormonal contraceptives, intrauterine devices, subdermal implantation, or hormonal vaginal ring. Exclusion Criteria: - Treatment of actinic keratoses in the décolleté area within the last 30 days. - Porphyria. - Pregnant or nursing women. - Skin cancer (invasive, in situ), keratoacanthoma, or other infiltrating tumors in the study area. - Known tendencies to produce hypertrophic scarring or keloids. - Allergies against Metvix creme solution, peanuts, or soy. - Considered unable to follow the study protocol, e.g. alcohol dependence syndrome. |
Country | Name | City | State |
---|---|---|---|
Denmark | Bispebjerg University Hospital | Copenhagen | Copenhagen NV |
Lead Sponsor | Collaborator |
---|---|
Merete Haedersdal |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Clinical improvement of photodamage | 5-point categorial scale of photodamage severity, measuring changes in skin texture, pigmentation, telangiectasia, and wrinkles. Scores are 0, 1, 2, 3, and 4, for none, mild, moderate, severe, and very severe, respectively. A reduction in score from initial scoring to post-treatment is desirable. | 12 weeks | |
Secondary | Treatment effect on actinic keratoses | Evaluated on the Olsen grading scale for actinic keratoses thickness. Scores are 1, 2, and 3, for slightly palpable, moderately thick, and very thick and hyperkeratotic, respectively. A reduction in score from initial scoring to post-treatment is desirable. | 12 weeks | |
Secondary | Severity of local skin reactions | Local skin reaction (LSR)-grading scale. Evaluation of redness, scaling, edema, pustules, and erosion on a 5-point categorial scale of severity. Scores are 0, 1, 2, 3, and 4, for individual parameters: Redness: None, slightly pink <50%, pink or light red >50%, red restricted to treatment area, and red extending outside treatment area. Scaling: None, isolated scale, scaling <50%, scaling >50%, scaling extending outside treatment area. Edema: None, slight specific edema, palpable edema beyond individual lesions, confluent and/or visible edema, and marked swelling extending outside treatment area. Pustules: None, vesicles only, transudate or pustules <50%, transudate or pustules >50%, and transudate or pustules extending outside treatment area. Erosion: None, lesion specific erosion, erosion extending beyond individual lesion, erosion >50%, and black eschar or ulceration. |
7 days | |
Secondary | Presence of perceived pain during treatment | VAS Visual analogue scale for perceived pain. Scores are 1, 2, 3, 4, 5, 6, 7, 8, 9, and 10, ranging from none to very severe. Higher is worse, and lower scores for treatment modalities are desirable. | 0 days | |
Secondary | Cosmetic results | Cosmetic results on a 5-point categorial scale for perceived cosmetic outcome compared with base starting point for the individual patient. Scores are 0, 1, 2, 3, and 4, for poor, acceptable, good, excellent, and outstanding, respectively. A higher score is desirable. | 12 weeks | |
Secondary | Protoporphyrin IX (PpIX) fluorescence uptake | Levels of PpIX uptake in the skin computed quantitatively from PpIX imaging. Imaging before application, after 3 hours, and after LED exposure. | 0 days | |
Secondary | Safety including wounding, scarring, hyper and hypo pigmentation | Safety concerning side-effects evaluated on a 5-point categorial scale for hyper- and hypopigmentation, erosions, and scarring. Scores are 0, 1, 2, 3, and 4, for none, mild, moderate, severe, and very severe. A lower score is desirable. | 12 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Suspended |
NCT03963102 -
Duration of Ameluz Application in Acral Actinic Keratoses Response
|
Phase 4 | |
Completed |
NCT01283464 -
Comparison of Retinol 1.0% and Tretinoin 0.02% in the Treatment of Moderate to Severe Photodamage and Wrinkles
|
Phase 2 | |
Active, not recruiting |
NCT06170346 -
Effect of Topical Agents With Various Antioxidant Containts on Photodamage Skin Induced
|
Phase 2 | |
Completed |
NCT02736760 -
Daylight-PDT With MAL for AK and Photodamaged Skin
|
Phase 4 | |
Active, not recruiting |
NCT05456334 -
New Treatments for Actinic Keratoses of the Scalp
|
N/A | |
Completed |
NCT05423873 -
A Multi-Center, Open-label Study Evaluate the Efficacy and Tolerability of a Dual Skincare Regimen Treatment for Facial Hyperpigmentation and Photodamaged Skin in Patients Exposed to Extrinsic Factors of Aging
|
N/A | |
Completed |
NCT03095872 -
Comparison of the Effect of Vaseline and Bepanthen® "Wund- Und Heilsalbe" on the Wound Healing Following Laser Therapy
|
Phase 3 | |
Not yet recruiting |
NCT05908825 -
Placebo-Controlled Study Assessing the Use of a Novel Exfoliative Serum With A Chemical Peel to Improve Photodamage in Adults
|
N/A | |
Active, not recruiting |
NCT05963204 -
A Study to Evaluate the Effects for Midface Improvement When Pairing a Biostimulator With a Skincare Regimen
|
N/A | |
Recruiting |
NCT04523961 -
Comparative Study of Two Topical Anesthetics Prior to Fractional Nonablative Laser Treatment of the Face
|
Phase 2/Phase 3 | |
Completed |
NCT01787461 -
A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure
|
Phase 4 | |
Recruiting |
NCT06351358 -
Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour Deficiencies
|
N/A | |
Completed |
NCT04065035 -
A Clinical Study to Evaluate Efficacy and Tolerability of a Cosmetic Product for Arm Firming
|
N/A | |
Active, not recruiting |
NCT04096742 -
Altreno for Chest Rejuvenation
|
Phase 4 | |
Completed |
NCT02693054 -
Safety and Efficacy Study for Various Skin Conditions
|
N/A | |
Terminated |
NCT00375141 -
Long-Pulsed Dye Laser and Intense Pulsed Light for Skin Rejuvenation.
|
N/A |